215 related articles for article (PubMed ID: 22689062)
21. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.
Wang Q; Zhu J; Wang YW; Dai Y; Wang YL; Wang C; Liu J; Baker A; Colburn NH; Yang HS
Oncogene; 2017 Nov; 36(45):6225-6234. PubMed ID: 28692058
[TBL] [Abstract][Full Text] [Related]
23. Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis.
Dennis MD; Jefferson LS; Kimball SR
J Biol Chem; 2012 Dec; 287(51):42890-9. PubMed ID: 23105104
[TBL] [Abstract][Full Text] [Related]
24. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
25. Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway.
Palaniappan M; Menon KM
Mol Endocrinol; 2010 Sep; 24(9):1782-93. PubMed ID: 20660299
[TBL] [Abstract][Full Text] [Related]
26. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.
Singh K; Lin J; Lecomte N; Mohan P; Gokce A; Sanghvi VR; Jiang M; Grbovic-Huezo O; Burčul A; Stark SG; Romesser PB; Chang Q; Melchor JP; Beyer RK; Duggan M; Fukase Y; Yang G; Ouerfelli O; Viale A; de Stanchina E; Stamford AW; Meinke PT; Rätsch G; Leach SD; Ouyang Z; Wendel HG
Cancer Res; 2021 Apr; 81(8):2002-2014. PubMed ID: 33632898
[TBL] [Abstract][Full Text] [Related]
27. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway.
Cao C; Huang X; Han Y; Wan Y; Birnbaumer L; Feng GS; Marshall J; Jiang M; Chu WM
Sci Signal; 2009 Apr; 2(68):ra17. PubMed ID: 19401591
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
Kharbanda A; Rajabi H; Jin C; Raina D; Kufe D
Mol Cancer Res; 2013 Jul; 11(7):714-23. PubMed ID: 23538857
[TBL] [Abstract][Full Text] [Related]
29. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
30. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A.
Yang HS; Cho MH; Zakowicz H; Hegamyer G; Sonenberg N; Colburn NH
Mol Cell Biol; 2004 May; 24(9):3894-906. PubMed ID: 15082783
[TBL] [Abstract][Full Text] [Related]
31. B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells.
Taylor J; Wilmore S; Marriot S; Rogers-Broadway KR; Fell R; Minton AR; Branch T; Ashton-Key M; Coldwell M; Stevenson FK; Forconi F; Steele AJ; Packham G; Yeomans A
Cell Signal; 2022 Jun; 94():110311. PubMed ID: 35306137
[TBL] [Abstract][Full Text] [Related]
32. FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation.
Nguyen TM; Kabotyanski EB; Dou Y; Reineke LC; Zhang P; Zhang XH; Malovannaya A; Jung SY; Mo Q; Roarty KP; Chen Y; Zhang B; Neilson JR; Lloyd RE; Perou CM; Ellis MJ; Rosen JM
Cancer Res; 2018 Aug; 78(15):4229-4240. PubMed ID: 29844125
[TBL] [Abstract][Full Text] [Related]
33. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of small molecules targeting eIF4A.
Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
36. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
[TBL] [Abstract][Full Text] [Related]
37. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.
Raina D; Kosugi M; Ahmad R; Panchamoorthy G; Rajabi H; Alam M; Shimamura T; Shapiro GI; Supko J; Kharbanda S; Kufe D
Mol Cancer Ther; 2011 May; 10(5):806-16. PubMed ID: 21421804
[TBL] [Abstract][Full Text] [Related]
38. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.
Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L
J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054
[TBL] [Abstract][Full Text] [Related]
39. A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1.
Tsai BP; Jimenez J; Lim S; Fitzgerald KD; Zhang M; Chuah CT; Axelrod H; Wilson L; Ong ST; Semler BL; Waterman ML
Open Biol; 2014 Nov; 4(11):140180. PubMed ID: 25392452
[TBL] [Abstract][Full Text] [Related]
40. S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
Ben-Hur V; Denichenko P; Siegfried Z; Maimon A; Krainer A; Davidson B; Karni R
Cell Rep; 2013 Jan; 3(1):103-15. PubMed ID: 23273915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
